Zhejiang Huahai Pharmaceutical Co., Ltd.
600521
株式のランク
#4298
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
株価
$2.42
時価総額
$3.62B
変化（1日）
-3.06%
変化（1年）
-8.97%
国
CN
取引 Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
カテゴリー
Healthcare
Zhejiang Huahai Pharmaceutical Co., Ltd.（600521）の株価履歴
終値の最高値: $2.43 （2026-10-01）
終値の最安値: $0.16 （2003-03-01）
終値の最安値: $0.16 （2003-03-01）
Zhejiang Huahai Pharmaceutical Co., Ltd. の株価履歴（2003 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | -3.88% |
| 2025 | -2.54% |
| 2024 | 21.89% |
| 2023 | -28.55% |
| 2022 | -8.10% |
| 2021 | -38.22% |
| 2020 | 124.56% |
| 2019 | 37.85% |
| 2018 | -48.65% |
| 2017 | 30.46% |
| 2016 | 14.37% |
| 2015 | 53.29% |
| 2014 | 11.91% |
| 2013 | 64.45% |
| 2012 | -5.96% |
| 2011 | -12.19% |
| 2010 | 9.52% |
| 2009 | 102.34% |
| 2008 | -28.32% |
| 2007 | 82.10% |
| 2006 | 48.93% |
| 2005 | -14.60% |
| 2004 | 67.52% |
| 2003 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
